89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 152 filers reported holding 89BIO INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,438,074 | -14.8% | 3,525,782 | +4.6% | 0.00% | -50.0% |
Q2 2023 | $63,860,383 | +60.9% | 3,369,941 | +29.3% | 0.00% | +100.0% |
Q1 2023 | $39,693,721 | +97.6% | 2,606,285 | +65.1% | 0.00% | 0.0% |
Q4 2022 | $20,091,695 | +107.6% | 1,578,295 | -5.6% | 0.00% | – |
Q3 2022 | $9,678,000 | +204.1% | 1,671,584 | +69.1% | 0.00% | – |
Q2 2022 | $3,182,000 | +108.1% | 988,352 | +143.8% | 0.00% | – |
Q1 2022 | $1,529,000 | -77.3% | 405,419 | -21.5% | 0.00% | – |
Q4 2021 | $6,746,000 | -43.3% | 516,144 | -15.0% | 0.00% | – |
Q3 2021 | $11,889,000 | +47.2% | 606,914 | +40.5% | 0.00% | – |
Q2 2021 | $8,077,000 | -22.3% | 431,935 | -1.5% | 0.00% | – |
Q1 2021 | $10,389,000 | +1.5% | 438,693 | +4.5% | 0.00% | – |
Q4 2020 | $10,231,000 | -27.3% | 419,802 | -23.5% | 0.00% | – |
Q3 2020 | $14,073,000 | +172.8% | 548,419 | +111.9% | 0.00% | – |
Q2 2020 | $5,159,000 | +117.7% | 258,830 | +175.7% | 0.00% | – |
Q1 2020 | $2,370,000 | -2.5% | 93,883 | +1.5% | 0.00% | – |
Q4 2019 | $2,431,000 | – | 92,477 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $173,880,118 | 3.94% |
Orchard Capital Management, LLC | 551,879 | $8,405,117 | 2.81% |
Cormorant Asset Management, LP | 2,800,000 | $42,644 | 2.81% |
SILVERARC CAPITAL MANAGEMENT, LLC | 438,215 | $6,674,014 | 2.76% |
Boxer Capital, LLC | 2,100,000 | $31,983 | 1.57% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,210,536 | $33,666,463 | 1.42% |
Resolute Capital Asset Partners LLC | 125,000 | $1,904 | 1.39% |
Velan Capital Investment Management LP | 98,500 | $1,500,155 | 1.28% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $3,046,000 | 1.26% |
Deep Track Capital, LP | 1,800,000 | $27,414,000 | 1.13% |